NEUCA S.A. (WSE:NEU)
Poland · Delayed Price · Currency is PLN 772.00
-12.00 (-1.53%)
Aug 14, 2026, 5:00 PM CET
NEUCA Financials Overview
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 13,835 | 13,644 | 12,612 | 11,813 | 11,232 | 9,864 |
Revenue Growth | 7.95% | 8.18% | 6.77% | 5.17% | 13.87% | 6.70% |
Gross Profit Gross Profit Growth | 1,592 | 1,556 | 1,438 | 1,305 | 1,124 | 992.04 |
Operating Income Operating Income Growth | 263.29 | 245.87 | 258.15 | 243.19 | 220.99 | 214.69 |
Net Income Net Income Growth | 175.55 | 155.58 | 154.24 | 146.27 | 137.24 | 150.66 |
Earnings Per Share EPS Growth | 38.31 | 34.05 | 34.01 | 32.48 | 30.00 | 32.51 |
EPS Growth | 19.12% | 0.12% | 4.71% | 8.27% | -7.72% | 1.66% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Insurance Business Insurance Business Growth | 218.16 | 212.79 | 192.81 | 134.95 | 102.54 | 24.68 |
Wholesale Distribution of Drugs (Including Marketing Services) Wholesale Distribution of Drugs (Including Marketing Services) Growth | 12,529 | 12,536 | 11,592 | 10,973 | 10,745 | 9,600 |
Clinical Research Clinical Research Growth | 463.45 | 460.33 | 451.63 | 403.78 | 196.05 | 133.56 |
Medical Operator Medical Operator Growth | 545.06 | 521.33 | 457.52 | 361.84 | 235.69 | 144.78 |
Production of Pharmaceuticals Production of Pharmaceuticals Growth | 490.33 | 443.63 | 365.81 | 357.32 | 315.99 | 201.06 |
Unallocated Adjustments Unallocated Adjustments Growth | - | -530.81 | -447.52 | -417.82 | -363.17 | -239.68 |
Total Total Growth | 13,835 | 13,644 | 12,612 | 11,813 | 11,232 | 9,864 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 185.27 | 168.62 | 143.94 | 119.55 | 225.87 | 89.18 |
Total Debt Total Debt Growth | 804.97 | 737.64 | 619.35 | 663.43 | 561.67 | 303.11 |
Net Cash (Debt) Net Cash Growth | -619.7 | -569.02 | -475.41 | -543.89 | -335.81 | -213.93 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -135.25 | -124.52 | -104.83 | -120.77 | -73.40 | -46.17 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 440.96 | 548.86 | 63.23 | 288.27 | 335.94 | 300.2 |
Capital Expenditures CapEx Growth | -128.18 | -124.88 | -92.91 | -94.18 | -81.45 | -52.75 |
Free Cash Flow Free Cash Flow Growth | 312.79 | 423.99 | -29.68 | 194.09 | 254.49 | 247.45 |
Free Cash Flow Growth | 2716.64% | - | - | -23.73% | 2.85% | 3.31% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 11.51% | 11.40% | 11.40% | 11.05% | 10.00% | 10.06% |
Operating Margin | 1.90% | 1.80% | 2.05% | 2.06% | 1.97% | 2.18% |
Pretax Margin | 1.63% | 1.50% | 1.80% | 1.73% | 1.82% | 2.05% |
Profit Margin | 1.27% | 1.14% | 1.22% | 1.24% | 1.22% | 1.53% |
FCF Margin | 2.26% | 3.11% | -0.24% | 1.64% | 2.27% | 2.51% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 17.800 | 17.800 | 16.000 | 14.500 | 13.000 | 11.500 |
Dividend Per Share Growth | 11.25% | 11.25% | 10.35% | 11.54% | 13.04% | 15.00% |
Dividend Yield | 2.31% | 2.24% | 1.92% | 1.67% | 2.17% | 1.51% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.15 | 23.35 | 25.28 | 27.88 | 20.60 | 24.53 |
Forward PE | 16.34 | 19.93 | 16.83 | 22.93 | 20.01 | 19.36 |
P/FCF Ratio | 11.16 | 8.57 | - | 21.01 | 11.11 | 14.93 |
PS Ratio | 0.25 | 0.27 | 0.31 | 0.35 | 0.25 | 0.38 |